5 November 2022
Ropes & Gray Advises TPG in Sale of Immucor to Werfen
Advising firms
Deal team
9 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Michael Roh Lead | Ropes & Gray | Partner | private equity | Not stated |
| James C. Davis Lead | Ropes & Gray | Partner | private equity | Not stated |
| Scott Rolnik | Ropes & Gray | Partner | private equity | Not stated |
| Adam Greenwood | Ropes & Gray | Partner | tax | Not stated |
| Matt Jones | Ropes & Gray | Partner | benefits | Not stated |
| Ruchit Patel | Ropes & Gray | Partner | litigation & enforcement | Not stated |
| Annie Herdman | Ropes & Gray | Partner | litigation & enforcement | Not stated |
| Walton Dumas | Ropes & Gray | Counsel | private equity | Not stated |
| Rebecca Yang | Ropes & Gray | Associate | private equity | Not stated |
6 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 2bn (approximately $2 billion)
- What the figure measures
- Total transaction value
- Client
- TPGSell-side
- Counterparties
- Werfen (Buy-side)
Immucor, Inc. (Target)